Crewe Advisors LLC Seagen Inc. Transaction History

Crewe Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 28, 2023	BUY	$187.64 - $206.25 $187 - $206	1 Added 3.85%	27 $5,000
Q1 2023 May 12, 2023	BUY	$127.59 - $203.08 $1,913 - $3,046	15 Added 136.36%	26 $5,000
Q4 2022 Feb 07, 2023	SELL	$117.37 - $139.17 $6,337 - $7,515	-54 Reduced 83.08%	11 $1,000
Q3 2022 Nov 14, 2022	BUY	$135.27 - $180.11 $1,758 - $2,341	13 Added 25.0%	65 $9,000
Q2 2022 Aug 02, 2022	BUY	$108.81 - $179.33 $5,658 - $9,325	52 New	52 $9,000

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Crewe Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Crewe Advisors LLC with notifications on news.